English | Español

Bristol-Myers Squibb
Robert Hadley | May 14, 2017

Bristol-Myers Squibb dual-drug treatment for hepatitis C gains China approval
Robert Hadley | May 14, 2017

Partnership to launch study of two drugs, chemotherapy to treat lung cancer
Chandra Lye | May 11, 2017

Opdivo given European approval for patients with head and neck squamous cell cancer
Robert Hadley | Apr 14, 2017

FDA to speed Opdivo review for use as colorectal cancer drug
Robert Hadley | Apr 10, 2017

Bristol-Myers Squibb to contunue testing Opdivo for brain tumors
Robert Hadley | Apr 7, 2017

Early tests show Opdivo triples life expectancy in lung-cancer patients
Kyle Perrotti | Apr 6, 2017

Parker Institute, Cancer Research Institute join forces for project
Erianne Leatherman | Apr 5, 2017

BMS, Foundation Medicine partner on predictive biomarker project

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Pharmaceuticals
Patient Daily | May 8, 2025

National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments